Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.44M 2.11M 1.99M 1.81M 230M 3.41M 23.51M 9.11M 118M 9.17M 8.97M 388M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.15M 2.72M 2.56M 2.34M 298M 4.4M 30.37M 11.76M 153M 11.85M 11.59M 501M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.43M | |
| +0.97% | -1.75% | +2.17% | +18.46% | 49.74B | |
| -0.30% | -1.02% | +451.04% | +496.95% | 44.98B | |
| +2.13% | +1.70% | +38.27% | +17.61% | 42.52B | |
| +0.87% | -3.88% | +18.21% | +73.17% | 40.78B | |
| -0.90% | -1.74% | +15.20% | +48.44% | 32.89B | |
| +2.71% | +5.66% | - | - | 17.09B | |
| +1.68% | -3.43% | +24.71% | +116.83% | 16.28B | |
| +1.70% | -1.75% | +12.00% | +28.50% | 14.4B | |
| +3.34% | -1.98% | +78.65% | +39.19% | 13.48B | |
| Average | -2.24% | -2.42% | +80.03% | +104.89% | 30.24B | |
| Weighted average by Cap. | +1.01% | -2.25% | +97.63% | +123.25% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.3M -1.12M -1.06M -965K -123M -1.82M -12.52M -4.85M -63.05M -4.89M -4.78M -207M | 5M 3.61M 3.12M 2.93M 2.68M 341M 5.04M 34.75M 13.46M 175M 13.56M 13.26M 573M |
| Net Debt | 795K 574K 496K 467K 426K 54.16M 801K 5.53M 2.14M 27.83M 2.16M 2.11M 91.19M | 986K 711K 615K 579K 528K 67.16M 994K 6.85M 2.65M 34.51M 2.67M 2.61M 113M |
Employees
-
